TIP60 mediated regulation of ΔNp63α is associated with Cisplatin resistance
About 5.4 million basal and squamous cell skin cancers are diagnosed each year in the US. Cisplatin, a chemotherapeutic drug is often used to treat squamous cell carcinoma (SCC) patients. However, 55% of cancers fail to respond leading to lower response rates and higher rates of disease re-occurrenc...
Saved in:
Published in | The FASEB journal Vol. 36 Suppl 1 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.05.2022
|
Online Access | Get more information |
Cover
Loading…
Be the first to leave a comment!